BRIEF published on 05/06/2026 at 00:25, 4 months 5 days ago Hillcrest Energy Technologies Shifts to Semi-Annual Reporting Financial Framework Canadian Securities Hillcrest Energy Semi-annual Reporting Venture Issuer
BRIEF published on 05/06/2026 at 00:25, 4 months 5 days ago Hillcrest Energy Technologies passe à un rapport semestriel Rapport Semestriel Valeurs Mobilières Canadiennes Cadre Financier Hillcrest Energy Émetteur De Capital-risque
BRIEF published on 05/06/2026 at 00:10, 4 months 5 days ago Study Reveals Rising Stroke Rates and Increasing Inequalities Prevention Efforts Socioeconomic Impact Stroke Rates Ethnic Disparities Healthcare Inequalities
BRIEF published on 05/06/2026 at 00:10, 4 months 5 days ago Une étude révèle une hausse des taux d'AVC et une augmentation des inégalités Impact Socio-économique Taux D'AVC Disparités Ethniques Inégalités En Matière De Soins De Santé Efforts De Prévention
BRIEF published on 05/06/2026 at 00:05, 4 months 5 days ago Onco-Innovations and GSK Collaborate to Enhance Oncology Evidence Clinical Trials Oncology GSK Real-world Data Onco-Innovations
BRIEF published on 05/06/2026 at 00:05, 4 months 5 days ago Onco-Innovations et GSK collaborent pour améliorer les données probantes en oncologie GSK Essais Cliniques Données Du Monde Réel Oncologie Onco-Innovations
BRIEF published on 05/05/2026 at 23:10, 4 months 5 days ago Norgine Secures TGA Approval for PEDMARQSI® in Australia Childhood Cancer TGA Approval PEDMARQSI® Cisplatin Hearing Loss Norgine Pharmaceuticals
BRIEF published on 05/05/2026 at 23:10, 4 months 5 days ago Norgine obtient l'approbation de la TGA pour PEDMARQSI® en Australie PEDMARQSI® Norgine Pharmaceuticals Approbation De La TGA Perte Auditive Due Au Cisplatine Cancer Infantile
BRIEF published on 05/05/2026 at 23:05, 4 months 5 days ago Viemed Healthcare Reports Strong Q1 2026 Financial Results Financial Results Revenue Growth Cash Flow Guidance Update Patient Count
BRIEF published on 05/05/2026 at 23:05, 4 months 5 days ago Viemed Healthcare annonce de solides résultats financiers pour le premier trimestre 2026 Résultats Financiers Croissance Des Revenus Des Flux De Trésorerie Mise À Jour Des Recommandations Nombre De Patients
Published on 09/11/2026 at 04:00, 5 hours 17 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 52 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 57 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 17 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:05, 12 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 17 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 09:00, 17 minutes ago Mountain Alliance AG invests in Evolved Aerospace and expands its involvement in the European defence technology market
Published on 09/11/2026 at 07:00, 2 hours 17 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 17 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 17 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 47 minutes ago Availability of the 2026 Interim Financial Report
